Tel/PDGFRbeta inhibits self-renewal and directs myelomonocytic differentiation of ES cells

Leuk Res. 2008 Oct;32(10):1554-64. doi: 10.1016/j.leukres.2008.02.007. Epub 2008 Mar 19.

Abstract

The leukemic oncogene Tel/PDGFRbeta, was inducibly expressed in embryonic stem (ES) cells and the phenotypic and molecular changes occurring during hematopoietic differentiation investigated. Expression of Tel/PDGFRbeta resulted in an inability of ES cells to self-renew and caused a significant increase in myelopoiesis with a corresponding decrease in erythropoiesis. Analysis of gene expression patterns indicated a dramatic alteration in the levels of genes associated with self-renewal and differentiation, especially myelomonocytic genes in Tel/PDGFRbeta-expressing cells. This study indicates Tel/PDGFRbeta drives myelopoiesis by altering expression of genes involved in hematopoiesis and demonstrates the potential of this stem cell system to study oncogene-induced pathogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Proliferation
  • Cell Survival
  • Cells, Cultured
  • Embryonic Stem Cells / cytology
  • Embryonic Stem Cells / metabolism*
  • Gene Expression Regulation
  • Hematopoiesis / genetics
  • Leukemia Inhibitory Factor / pharmacology
  • Mice
  • Myeloid Cells / cytology
  • Myelopoiesis*
  • Oncogene Proteins, Fusion / metabolism*

Substances

  • Leukemia Inhibitory Factor
  • Oncogene Proteins, Fusion
  • TEL-PDGFRbeta fusion protein, human